A Promising Approach of Dermal Targeting of Antipsoriatic Drugs via Engineered Nanocarriers Drug Delivery Systems for Tackling Psoriasis
Authors:
- 1 July 2023
- journal article
- review article
- Published by Bentham Science Publishers Ltd. in Drug Metabolism Letters
- Vol. 16 (2) , 89-104
Abstract
Psoriasis is a complex autoimmune skin condition with a significant genetic component. It causes skin inflammation and is characterized by flaky, silvery reddish spots that can worsen with age. This condition results from an impaired immunological response of T-cells and affects 2-5% of the global population. The severity of the illness determines the choice of treatment. Topical treatments are commonly used to treat psoriasis, but they can have several adverse effects. Biological therapy is another option for treating specific types of psoriasis. Recently, new nanoformulations have revolutionized psoriasis treatment. Various nanocarriers, such as liposomes, nanostructured lipid nanoparticles, niosomes, and nanoemulsions, have been developed and improved for drug delivery. The use of nanocarriers enhances patient compliance, precise drug delivery, and drug safety. This review aims to suggest new nanocarrier-based drug delivery systems for treating psoriasis. It discusses the importance of nanocarriers and compares them to traditional treatments. Anti-psoriatic drugs have also been investigated for cutaneous delivery using nanocarriers. The review also covers various factors that influence dermal targeting. By highlighting several relevant aspects of psoriasis treatment, the review emphasizes the current potential of nanotechnology. Using nanocarriers as a drug delivery technique may be a promising alternative treatment for psoriasis.Keywords
This publication has 102 references indexed in Scilit:
- Dermal γδ T cells — A new player in the pathogenesis of psoriasisInternational Immunopharmacology, 2013
- Psoriatic arthritisPolish Journal of Radiology, 2013
- Physico-chemical characteristics of methotrexate-entrapped oleic acid-containing deformable liposomes for in vitro transepidermal delivery targeting psoriasis treatmentInternational Journal of Pharmaceutics, 2012
- Dermal targeting of tacrolimus using colloidal carrier systemsInternational Journal of Pharmaceutics, 2011
- Targeting tacrolimus to deeper layers of skin with improved safety for treatment of atopic dermatitisInternational Journal of Pharmaceutics, 2010
- Patient preferences and satisfaction with systemic therapies for psoriasis: an area to be exploredBritish Journal of Dermatology, 2009
- Biologic therapies in psoriasis: A new therapeutic approachAutoimmunity Reviews, 2007
- Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical deliveryInternational Journal of Pharmaceutics, 2007
- Expression of the corticotropin‐releasing hormone–proopiomelanocortin axis in the various clinical types of psoriasisExperimental Dermatology, 2006
- The Role of PUVA in the Treatment of PsoriasisAmerican Journal of Clinical Dermatology, 2000